Skip to main content
DrugPrice

Drug Discount Card

A free card or app (like GoodRx) that provides negotiated prescription discounts at retail pharmacies, separate from insurance.

How It Works

Drug discount cards operate as prescription discount networks that contract with PBMs to provide members access to negotiated cash-pay rates at retail pharmacies. The patient presents the card or app-generated BIN/PCN/group numbers at checkout, and the claim processes as a discount card transaction rather than an insurance claim. GoodRx, founded 2011, is the market leader with roughly 20+ million monthly users in 2024; competitors include SingleCare, RxSaver, Optum Perks, Blink Health, America's Pharmacy, and WellRx. The discount card business model generates revenue from "transaction fees" paid by the contracted PBM (typically $1-5 per fill), shared with the discount card operator. For many generic drugs, discount card prices run lower than insurance copays, particularly for patients with high-deductible plans or in the deductible phase. A 30-day supply of generic sertraline might be $4 with a GoodRx coupon vs. $15 insurance copay. However, discount card prescriptions do not count toward insurance deductibles or OOP maximums, and cannot be combined with insurance (you use one or the other). Discount card coverage is typically strong for generics and some low-rebate brands, weaker for specialty drugs and high-rebate brands where PBM-contracted rates are uncompetitive vs. insurance plus manufacturer copay card. The discount card space has consolidated: GoodRx acquired RxSaver (2020) and Scriptco (2022), Cigna acquired Express Scripts which acquired RightRx. GoodRx Holdings went public in 2020 (NASDAQ: GDRX) and reports detailed transaction volume. Discount cards do not themselves set prices, they aggregate PBM-negotiated rates, which is why Cost Plus Drugs represents a genuinely different model (pharmacy ownership and direct manufacturer relationships).

Related Terms

  • Cost Plus Pharmacy, A pharmacy model that sells generic drugs at acquisition cost plus a fixed markup (typically 15%) and a dispensing fee, bypassing the traditional PBM-driven pricing system.
  • Pharmacy Benefit Manager (PBM), A company that acts as a middleman between drug manufacturers, insurers, and pharmacies, negotiating drug prices, managing formularies, and processing claims.
  • Out-of-Pocket Cost, The amount a patient pays directly for a prescription drug, including copays, coinsurance, and deductible payments.
  • Generic Drug, A medication that contains the same active ingredient, dosage, and form as a brand-name drug, approved after the original's patent expires, typically costing 80-95% less.

Explore Drug Data

Most Expensive DrugsGeneric Drug WatchSearch All Drugs

About This Definition

This definition is part of the DrugPrice Drug Pricing Glossary, 49 terms explaining how prescription drug pricing works in the United States. All definitions are written in plain language for patients, caregivers, journalists, and healthcare professionals.

this entity is one of the U.S. Medicare prescription-drug pricing concepts that recurs across this site. The definition above is the technical answer; the paragraphs below add the practical context for how the concept connects to the CMS Medicare Part D Drug Spending data data behind every per-entity page on the site.

In the CMS Medicare Part D Drug Spending data data, this concept shapes one or more of the fields that drive the per-entity grades and rankings on this site. The methodology page describes which fields feed into which output; this glossary entry documents the underlying term.

Source: CMS Medicare Part D Spending, 2026.